GlaxoSmithKline Said to Plan Reorganization, U.S. Cuts
This article is for subscribers only.
GlaxoSmithKline Plc is planning a reorganization that will include hundreds of job cuts in the U.S., people familiar with the situation said.
The drugmaker is poised to announce a workforce restructuring as soon as this week, said the people, who asked not to be identified discussing a private company matter. The changes will involve operations in the U.S., where London-based Glaxo has struggled to sell respiratory medicines in recent months. Deirdre Connelly, president of North American operations, is scheduled to speak to U.S. employees on Dec. 3, two people said.